Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03482674
Other study ID # 01NVF17012
Secondary ID
Status Recruiting
Phase N/A
First received March 6, 2018
Last updated April 4, 2018
Start date January 2, 2018
Est. completion date July 1, 2020

Study information

Verified date April 2018
Source Dimini Konsortium
Contact Carsten Petersen, Dr.
Phone +494621-855 425
Email c.petersen@internisten-schleswig.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The increasing prevalence of type 2 diabetes mellitus is a worldwide problem. In preventing risk factors and unhealthy lifestyle through improved health literacy, chances are seen to delay or even avoid type 2 diabetes mellitus. The aim of the DIMINI-project is to prevent type 2 diabetes mellitus and to strengthen the health literacy of people at increased risk of developing it. For this purpose, people at increased risk are first identified by using the standardized screening tool Finnish Diabetes Risk Score (FINDRISC) adapted for Germany. Identified risk persons then receive a needs-based, modular lifestyle intervention including nutrition tips and physical exercises either paper- or app-based.


Description:

DIMINI, a randomised controlled trial, will assess whether the implementation of a lifestyle intervention for people at increased risk of developing type 2 diabetes mellitus will result in an improvement in body weight (primary outcome) and participants health literacy (secondary outcome) or not. A three-month intervention in the intervention group is followed by a one-year follow-up. The control group receives standard care as provided by the German statutory health insurance for three months and a one-year follow-up as well.


Recruitment information / eligibility

Status Recruiting
Enrollment 530
Est. completion date July 1, 2020
Est. primary completion date March 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age = 18 years

- resident in Hesse or Schleswig-Holstein

- statutory health insurance in one out of five participating health insurances

- overweight/obesity

- low physical activity

- known family disposition for type 2 diabetes mellitus

- history of increased glucose levels

- FINDRISC results with scores = 12

Exclusion Criteria:

- age < 18 years

- resident outside Hesse or Schleswig-Holstein

- statutory or private health insurance with other than the participating health insurances

- clinically manifested diabetes mellitus

- malnutrition

- psychiatric disorders

- pregnancy

- FINDRISC results with scores <12

- participation in other clinical trials

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
DIMINI lifestyle intervention
DIMINI lifestyle intervention consists of the DIMINI-kit which contains health information, a list of food recommendations with additional information on calories, serving size and weight (traffic light rating system), a nutrition and an exercise diary. Participants in the intervention group can choose between a paper-based version or an app-based version of the DIMINI-kit. In addition, the kit includes an elastic exercise band with exercise poster, a measuring tape for self-control of the waist size and a pedometer.

Locations

Country Name City State
Germany docevent GmbH Schleswig Schleswig-Holstein

Sponsors (2)

Lead Sponsor Collaborator
Dimini Konsortium Deutsche Diabetes Gesellschaft

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body weight reduction Survey of weight general practitioners level 15 Months
Secondary Health literacy (European Health Literacy Survey Questionnaire) Summed scale:
Maximum: 16 (best health literacy)
Minimum: 0 (worst health literacy)
= 13 = sufficient health literacy
9-12 = problematic health literacy
= 8 = inadequate health literacy Higher values represent a better outcome
15 Months
Secondary Eating behaviour (German questionnaire on eating behaviour) Three summed subscales:
Scale 1) cognitive control of eating behavior, restrained eating
Minimum score: 0 = no cognitive control
Maximum score: 21 = extreme cognitive control Scale 2) disturbance of eating behavior
Minimum score: 0 = no disturbance
Maximum score: 16 = extreme disturbance Scale 3) experienced feelings of hunger
Minimum score: 0 = no disturbing sensations of hunger
Maximum score: 14 = very strong disturbing sensations of hunger For each item it is determined individually, which response option is considered to get a value of 1 or a value of 0 (e.g. Scale 1 Item 12: "true" = 1, "not true" = 0, Item 18 "true" = 0, "not true" = 1)
15 Months
Secondary Physical activity (International Physical Activity Questionnaire) Questionnaire designed for population surveillance of physical activity among adults including
Total Score:
Maximum Score: 960 minutes
Minimum Score: 10 minutes
Categorical Score:
Category 1 - Low:
• Individuals who not meet criteria for Categories 2 or 3
Category 2 - Moderate:
3 or more days of vigorous-intensity activity of at least 20 minutes per day
5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day
5 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum total physical activity of at least 600 minutes/week.
Category 3 High
vigorous-intensity activity on at least 3 days achieving a minimum total physical activity of at least 1500 minutes/week
7 or more days of any combination of walking, moderate-intensity or vigorous-intensity activities achieving a minimum total physical activity of at least 3000 minutes/week.
15 Months
Secondary Quality of life Short Form 12 15 Months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2